Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Stem Cell Transplant Recipient”

79 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 79 results

Not applicableLooking for participantsNCT04689750
What this trial is testing

Donor CHIP and Allogeneic HSCT Outcome

Who this might be right for
Clonal Hematopoiesis
The University of Hong Kong 850
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Early research (Phase 1)Study completedNCT04220684
What this trial is testing

Trial Testing Safety of IL-21 NK Cells for Induction of R/R AML

Who this might be right for
Allogeneic Stem Cell Transplant RecipientBlasts 10 Percent or More of Bone Marrow Nucleated CellsRecurrent Acute Myeloid Leukemia+1 more
Sumithira Vasu 19
Large-scale testing (Phase 3)Study completedNCT03565900
What this trial is testing

Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Who this might be right for
Pneumococcal Infections
Merck Sharp & Dohme LLC 277
Testing effectiveness (Phase 2)Ended earlyNCT01629511
What this trial is testing

Allogeneic Stem Cell Transplant for CLL

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation RecipientChronic Lymphocytic LeukemiaProlymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 15
Not applicableStudy completedNCT06704243
What this trial is testing

Peer Support Group for Adolescent and Young Adult (AYA) Allogeneic Stem Cell Transplant Recipients

Who this might be right for
CancerLeukemiaStem Cell Transplant
University Health Network, Toronto 13
Very early researchEnded earlyNCT03272633
What this trial is testing

Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia in RemissionHematopoietic Cell Transplantation Recipient+16 more
Rutgers, The State University of New Jersey 2
Testing effectiveness (Phase 2)WithdrawnNCT04127721
What this trial is testing

Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell Transplant RecipientHematologic and Lymphocytic DisorderHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT01026987
What this trial is testing

Granulocyte Colony-stimulating Factor (G-CSF) Plus or Minus AMD3100 for Engraftment Post Allogeneic Transplant

Who this might be right for
Stem Cell Transplant Patients
Washington University School of Medicine 29
Testing effectiveness (Phase 2)Ended earlyNCT01640301
What this trial is testing

Laboratory-Treated T Cells in Treating Patients With High-Risk Relapsed Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Recurrent Adult Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia+5 more
Fred Hutchinson Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT01573182
What this trial is testing

Herpes Zoster Vaccine for Bone Marrow Transplant Donors

Who this might be right for
Herpes Zoster
University of Sydney 8
Early research (Phase 1)Looking for participantsNCT03494569
What this trial is testing

Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia in RemissionAcute Myeloid Leukemia+5 more
City of Hope Medical Center 36
Not applicableUnknownNCT05692713
What this trial is testing

Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201)

Who this might be right for
Chronic Graft-versus-Host-DiseaseAllogeneic Hematopoietic Stem Cell TransplantationLeukemia+2 more
University of British Columbia 320
Not applicableStudy completedNCT03401268
What this trial is testing

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Hypogammaglobulinemia
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Looking for participantsNCT07214688
What this trial is testing

Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

Who this might be right for
Allogeneic Stem Cell Transplant Recipient
Hackensack Meridian Health 209
Early research (Phase 1)Study completedNCT00423774
What this trial is testing

Education Program to Manage Emotional Stress of Stem Cell Transplant Recipients and Their Caregivers

Who this might be right for
Family CaregiversBone Marrow Transplantation
National Institutes of Health Clinical Center (CC) 20
Not applicableActive Not RecruitingNCT04160390
What this trial is testing

Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientDonorMalignant Neoplasm
City of Hope Medical Center 72
Testing effectiveness (Phase 2)Study completedNCT00006184
What this trial is testing

Chemotherapy, Stem Cell Transplantation and Donor and Patient Vaccination for Treatment of Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Ended earlyNCT01135537
What this trial is testing

Pharmacokinetics of Thymoglobulin in Paediatric Haematopoietic Stem-cell Transplants

Who this might be right for
MalignancyMetabolic DiseaseGenetic Disorder
The Hospital for Sick Children 30
Testing effectiveness (Phase 2)Looking for participantsNCT03779854
What this trial is testing

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaAcute Leukemia of Ambiguous Lineage+14 more
Fred Hutchinson Cancer Center 68
Load More Results